Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Tesamorelin: FDA-approved as Egrifta and Egrifta WR, but only for visceral fat reduction in HIV-associated lipodystrophy
Initial results from a randomized controlled trial indicated that it reduced weight and improved diabetic control
Supplementary Table 16 (download XLSX The predictions of multi-task neural-network model ensemble for glucagon-like peptide-1 orthologues sequences collected from the NCBI database
Energy expenditure, VO 2 , VCO 2 , respiratory exchange ratio, food intake, and water intake were measured continuously and simultaneously at a sampling frequency of 5 times per minute
US$ 23.42
US$ 28.10
US$ 20.13
US$ 24.49
